PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity

By Zhang Zhong-Yin   Lee Seung-Yub  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 223-233

Informa Healthcare

Access to resources Recommend Favorite

Assessment of pharmacology and potential anti-obesity properties of H₃ receptor antagonists/inverse agonists

By Hancock Arthur A   Brune Michael E  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 223-241

Informa Healthcare

Access to resources Recommend Favorite

The potential use of selective 5-HT_2C agonists in treating obesity

By Smith Brian M   Thomsen William J   Grottick Andrew J  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

5-HT2C Receptor Agonists as Potential Drugs for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 885-897

Bentham Science Publishers

Access to resources Recommend Favorite

3 -Adrenoceptor agonists: potential, pitfalls and progress

By Arch J.R.S.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 99-107

Elsevier

Access to resources Recommend Favorite